FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Dexrazoxane Injection
Status: Currently in Shortage
»Date first posted: 07/05/2017
»Therapeutic Categories: Oncology; Pediatric

Expand all

Clinigen Healthcare Ltd (Revised 07/26/2017)

Company Contact Information:
615-255-0068

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Totect® (Dexrazoxane) for injection; 1 vial (500 mg)(NDC 66220-110-01) Available to order 17 July; available to ship 25 July. Orders can be placed from 17 July 2017 with Clinigen Healthcare Ltd’s distributor for Cardioxane in the US, Cumberland Pharmaceuticals Inc., at 615-255-0068. Available

Hikma Pharmaceuticals USA, Inc. (formerly West-Ward) (Reverified 04/05/2019)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
250 mg per vial (NDC 0143-9247-01) Inventory is currently available Additional lots are scheduled to be manufactured in the February – March 2019 timeframe. Product will be made available as it is released. Demand increase for the drug
500 mg per vial (NDC 0143-9248-01) Inventory is currently available Additional lots are scheduled to be manufactured in the April 2019 timeframe. Product will be made available as it is released. Demand increase for the drug

Mylan Institutional (Revised 04/17/2019)

Company Contact Information:
800-RXMYLAN (1-800-796- 9526)

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
250 mg Kit (NDC 67457-207-25) Unavailable. Expected recovery: May 2019 Demand increase for the drug
500 mg Kit (NDC 67457-208-50) Unavailable. Expected recovery: May 2019 Demand increase for the drug

Pfizer Pharmaceuticals (Reverified 04/09/2019)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Zinecard 250 mg; Single Dose Vial (NDC 00013-8717-62) Available Available Other
Zinecard 500 mg; Single Dose Vial (NDC 00013-8727-89) Next Delivery and Estimated Recovery: September 2019 Shortage per Manufacturer: Manufacturing Delay Other

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English